V1 Middle East's 10 Successful Magnetic Leaders Revamping The Healthcare.pdf

CI
AUGUST
ISSUE : 01
2023
Revolu onizing Healthcare
Cu ng-Edge Innova ons
and Breakthroughs
in Healthcare Industry
Pg.No: 20
Pg.No: 28
Middle East's
SUCCESSFUL
Magnetic
Leaders
Revamping
The Healthcare
Commi ed Mission to
Heal and Transform Lives
The Future of
Healthcare
Unleashing the Power
of Technology

“I believe that the
greatest gift you can
give your family and
the world is a
healthy you.
”
– Joyce Meyer

Editor’s
Note
n the ever-evolving landscape of healthcare, visionary
Ileaders are emerging as catalysts for transformation.
Their strategic vision and innovative approach are
reshaping the industry to meet the demands of the modern
world. From leveraging cutting-edge technologies to
advocating for equitable access, these leaders are propelling
healthcare into a new era.
These trailblazers understand the potential of technologies
like artiﬁcial intelligence, telemedicine, and data analytics.
By harnessing AI's diagnostic prowess and enhancing
remote patient care through telemedicine, they are breaking
barriers to quality healthcare. Simultaneously, their
emphasis on data-driven decision-making is fostering more
informed and precise medical interventions.
Yet, these leaders go beyond technology. They're
championing inclusivity, striving for a healthcare system
that leaves no one behind. By advocating for aﬀordable
care, addressing health disparities, and promoting
preventative measures, they're forging a path toward greater
health equity.
Proactive
Leaders
Spearheading
Healthcare

In an era deﬁned by global challenges, these healthcare
leaders inspire hope. In the latest edition of The CIO
World - Middle East's 10 Successful Magnetic Leaders
Revamping The Healthcare Vol II, their dedication to
innovation and compassion serves as a beacon for the
industry, demonstrating that progress is not only possible
but essential for the well-being of society at large.
-Prh D. Bombarde
CIO

TableOF
CONT
ENTS
Ar cles
Cu ng-Edge Innova ons
and Breakthroughs in
Healthcare Industry
Unleashing the Power
of Technology
The Future of Healthcare
20
28

Mark
LevittCommi
ed
Mission
to
Heal
and
Transform
Lives
Ryan
Fernandes
Pioneering
Growth
and
Brand
Transforma
on
in
Healthcare
Yuval
Harpaz
Sharing
Innova
ve
Exper
se
For
Two
Decades
Dr.
Eng.
Basma
El
Zein
Unleashing
the
Power
of
Nanotechnology
for
Sustainable
Development
Goals
Cover
Story
Proﬁle CXO
08
16
32
24

CREDITS
THE
INSPIRING THE BUSINESS WORLD
CI
Circula on Manager
Research Analyst
Editor-in-Chief
Business Development Execu ves
Managing Editor
Business Development Manager
Art & Design Head
Art & Design Assistant
Visualiser
Co-designer
Marke ng Manager
Technical Consultants
Technical Head
Assistant Technical Head
SME-SMO Execu ve
Digital Marke ng Manager
Assistant Digital Marke ng Manager
Sales Execu ves
Execu ve Editor
Nicole Smoot
Sarah Miller
Chidiebere Moses O.
Nancy B., Sarah M.
Jane Adans
Prashik Bombarde
Jaine Woods
Deepanjali Jena
Paul White
Lisa Jones
Lexi Morgan
David Walker
Lilly Jacob
Jason Miller
Michael D., Aaron S.
Prachi Mokashi
Adiba Tarade
Bella Smith
C R E D I T S
Copyright © 2023 Insights Success Media and Technology
Pvt. Ltd., All rights reserved. The content and images used in
this magazine should not be reproduced or transmitted in
any form or by any means, electronic, mechanical,
photocopying, recording or otherwise, without prior
permission from Insights Success. Reprint rights remain
solely with Insights Success.
Follow us on
www.facebook.com/thecioworld
www.twitter.com/thecioworld
Corporate Ofce
Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin, OH 43017, United States
Phone - (614)-859-2600
Email: info@thecioworld.com
For Subscription: www.thecioworld.com
We are also available on
RNI No.: MAHENG/2018/75953
Issue 01 | August | 2023
Renuka Kulkarni

S
BiondVax
Pharmaceu cals Ltd.
biondvax.com
Amir Reichman
Chief Execu ve Officer
Amir is experienced in leading
people, building diverse teams,
working with interna onal
teams, recrui ng and developing
talent, ensuring all staff has
personal development plans,
empowering people, team
building, and culture se ng.
Pharmatrade
pharmatradeuae.com
Rapid Medical
rapid-medical.com
Mahmoud Medhat
General Manager
James R.
President
Mahmoud is an experienced
Medical Manager with a
demonstrated history of working
in the pharmaceu cals industry.
Skilled in Business Planning,
Medical Devices, Management,
Capital Equipment, and Healthcare.
James R. is an experienced
leader with a demonstrated
history of fueling growth
across mul ple sectors of
the medical device industry.
Levi Oncology Associates Ltd.
levi oncology.com
Mark Levi
CEO
Mark has speciali es in Medical
Oncology, Radia on Oncology
Cancer Research, Internal
Medicine, Pharmaceu cal R&D,
Pharmaceu cal Business
Development, Strategy, and
Biotechnology.
CytoReason
cytoreason.com
David Harel
Co-founder and CEO
David is well rounded business
leader with proven strategic thinking
and demonstrated execu on in
healthcare, technology, and finance.
Expert at evalua ng business models,
crea ng targeted go-to-market plans,
and focusing on the right opportuni es.
Featuring
Company
Brief
Featuring
Company
Brief
Quris Technologies Ltd.
quris.ai
Isaac Bentwich
Founder and CEO
Isaac is a seasoned
entrepreneur. Founded
and led three successful
tech companies that
became world-leaders in
their fields, leading
revolu ons in medicine,
gemonics and agriculture.
KAMADA
kamada.com
Yuval Harpaz
IT Director
Yuval has 20 years of total
experience, with 7 years as a
CIO New Informa on
Technologies adopter i.e.
CRM applica ons, Cloud
based solu on, Cyber
security products leader and
team player.
Prilenia
prilenia.com
Michael Mbchb
Chief Execu ve Officer
Michael is a Scien st, Physician
and Entrepreneur. He is the
CEO of Prilenia Therapeu cs
and a Killam Professor at the
University of Bri sh Columbia.
Evogene
evogene.com
Ofer Haviv
President & CEO
Ofer is President & CEO of
Evogene, a leading computa onal
biology company focused on
revolu onizing life-science
product development.
Aster DM Healthcare
asterdmhealthcare.com
Ryan Fernandes
Head of Marke ng - GCC
Ryan is a seasoned eCommerce
and Marke ng professional with
over 20 years of experience
across Middle East, Africa,
UK and India.
Featuring
Company
Brief

Story
Mark L. Levitt, MD, PhD
CEO

Commi ed Mission to
Heal and Transform Lives
For me, the trick is
never to lose sight
that helping others is
the primary driver—
not the money.

It’s a brave new world of cancer!
You see it everywhere: in the
news, on your social media
feed, and in your friends’
lives. If you’re not careful, you could
become collateral damage—and you
might even miss out on the incredible
advancements that are happening right
now to help treat cancer and make sure
that those who are sick can get the care
they need.
We understand that there are numerous
approaches to the challenge of
improving cancer treatments and
assisting humanity. But one thing is
certain: if we are to effect change and
ensure that people with cancer have
access to better treatments, we must
first ensure that better treatments
become available and that everyone
understands what the right treatments
from the right doctors are.
In order to improve upon the currently
available treatments, Dr. Mark L.
Levitt, MD, Ph.D., established Levitt
Oncology Associates Ltd. to help
advance new treatments in their
development and speed the availability
of such treatments to patients in need.
He is a man of science with a passion
for helping others. He was driven to
make a difference in the world and to
help those with cancer by making sure
that cancer therapy research and
development would advance and
provide new and better treatment
options.
Mark was determined to be a leader in
cancer research and treatments, and he
was inspired by the advances being
made in the medical field. He
dedicated himself to finding ways to
improve the treatments available to
cancer patients and to make sure that
those suffering from the disease could
benefit from the best possible
treatments, as current therapeutic
options leave much to be desired and
also come with a great cost in toxicity
for the patient.
Mark’s hard work and dedication have
made an impact in the fight against
cancer. He has both performed research
and advised numerous companies to
help develop treatments that provide
more effective and compassionate care
for those suffering from cancer.
Mark’s dedication and commitment
have been an example of how a single
person can make a positive difference
in the world and have inspired many
other individuals to continue the fight
against cancer and to make sure those
suffering from the disease can access
the best treatments available, making
him a beacon of hope in the fight
against cancer.
As we illuminate Dr. Levitt’s accom-
plishments and discover how his
ambition is changing lives, let’s
comprehend his remarkable path.
From College Dream to Oncology
Research Leadership: A Journey to
Help Mankind
When asked about his career path and
how his passion for helping people
helped him become a great oncologist,
Mark said, “I decided that I wanted to
be an oncologist when I was still in
college because cancer was the leading
cause of morbidity and mortality
among diseases, and I wanted to
dedicate my life to helping mankind.”
He decided to devote his career to
research in order to create new
treatments for cancer patients after
realizing that the available options—all
chemotherapy at the time—were
insufficient and extremely hazardous.
He completed an MD-PhD program
and an internal medicine residency.
These steps brought him to the NIH,
and a fellowship in medical oncology,
beginning his career as a lung cancer
researcher.
After completing his education, he
obtained a post at the University of
Pittsburgh and continued his research
at Allegheny University as a member
of the first generation of translational
cancer researchers with a foot in the
lab and a foot in the clinic. He rose to
prominence in his field in the US and
later realized a longstanding ambition
by returning his family to Israel after
two millennia in the Diaspora. He
continued his academic career at the
Sheba Medical Center, one of the top
ten hospitals in the world, while also
serving as an adjunct professor at the
University of Pittsburgh for a number
of years.
He started his transition to the industry
during that period with a number of
start-ups, followed by a term at Teva
Pharmaceuticals as the company’s
Head of Oncology in the Global
Business Development division. He
established Levitt Oncology Associ-
ates, Ltd. in 2013 to provide consul-
tancy services for drug development
from target identification to clinical
development. Thus, to realize his aim
of providing cancer patients with
improved medicines, he now aids
numerous businesses engaged in all
facets of cancer drug development.
Leveraging Experience to Advance
Cancer Treatments
In order to support start-ups and small
companies in clinical development,
business development, and strategy,
Levitt Oncology Associates, Ltd. was
established in 2013 using the enormous
experience that Mark had acquired in
Rise to the Challenge of Bringing Better Treatments and Helping Mankind.

For the last decade,
Dr. Mark Levitt has been
a driving force in the
pharmaceutical industry,
launching groundbreaking
research projects and
developing new treatments.

academic and biopharmaceutic
oncology. However, in a short period
of time, the focus widened to include
preclinical development, target
discovery, NASDAQ-listed companies,
and, occasionally, Big Pharma.
Geographically speaking, his initial
objective was to support the develop-
ment of oncology-focused biotechnol-
ogy in Israel, but Levitt Oncology
currently serves clients all over the
world. The major objective is still to
contribute to the creation of better
cancer treatments.
Since Levitt Oncology’s beginning, he
has served as its owner and CEO and
has taken on nearly all of the projects
himself because most of his clients
specifically request him for the
contract that has been agreed upon.
Transforming Oncology Care
Through Promising Projects -
Taking Risks and Embracing
Change
Mark thinks the secret lies in how to
approach promising projects. He
discovered that in order to advance in
the treatment of disease, one must be
able to see the biology of a disease and
the clinical disease entity as one
coherent process. He learned this as a
first-generation translational oncology
physician. The “facts” of today
shouldn’t be taken too seriously,
though, because many of them will be
replaced by new “facts” tomorrow.
As science advances and is able to
delve deeper into the biology of
disease, new understandings will
enable the creation of new and
improved therapies. Of course, in order
to benefit from fresh information, one
needs to maintain an open mind and be
willing to examine ideas that are not
necessarily popular right now.
The ability to be contrarian and take
big risks is frequently required for
identifying and developing potentially
disruptive technology. Science
advances through quantum leaps, with
less creative research filling in the finer
details between each leap. He believes
that Levitt Oncology is well-positioned
to take advantage of this philosophy,
given his background, which includes
substantial experience working as an
oncologist and cancer researcher in
university and biopharma settings.
Moreover, the ability to constantly
reinvent oneself and one’s business is
essential for remaining at the forefront
of innovation.
Navigating the Oncology Landscape
with Cutting-edge Technology
Navigating the oncology landscape can
be a complex and daunting task. With
the help of cutting-edge technology,
oncologists can stay ahead of the curve
and stay informed about the latest
treatments, therapies and clinical trials.
From cloud computing and telecom-
munication platforms to advanced
databases, oncologists can make use of
the latest advancements in technology
to stay up to date on the most effective
treatments and to give their patients the
best care possible.
By leveraging the most innovative and
cutting-edge technologies, one can stay
ahead of the curve and make sure to
have the best chance of developing
successful, life-saving treatments for
patients. Mark says, “The trick is not
having the trendiest technology but
getting involved with companies that
are working on novel technologies of
the future, forcing me out of my
comfort zone and keeping my skills at
the cutting edge.”
Unraveling the Complexities of
Biotech/ Biopharma
The biotech/biopharma sector is quite
intriguing. Development takes years,
and the results are far less guaranteed
than with high-tech. In order to
succeed in this field, several challeng-
ing issues must be resolved. For
instance, corporate executives and
scientists/clinicians may have different
perspectives on the company’s
objectives and frequently don’t fully
comprehend one another (even if they
think they do). Even worse are
instances in which business people
mistakenly believe themselves to be
scientists or vice versa.
A person with exceptional talent in
both fields is uncommon. Although
there are numerous aspects that
influence success, not all of them are
within one’s control. He is always
surprised to find the attitude that a
well-run business is first priority, ahead
of science. While it is true that an
administratively and financially sound
company is crucial to the success of a
product, it is even more crucial that the
research is sound, supports the
product’s disruptive potential, and is
emphasized throughout the drug’s
development. While a product with
solid scientific backing can succeed
even under inadequate corporate
management, even the best administra-
tion cannot overcome a product that
does not work.
The recent COVID-19 pandemic, in his
opinion, was instructive because a
large portion of the governmental
leadership followed their preconceived
notions of what would work, and as a
result, they have few drugs that are
actually very effective despite
enormous efforts and hundreds of
billions of dollars invested. He calls
this phenomenon the “Lemming
effect,” inferring people would rather
fail conventionally than take chances
going against conventional wisdom to
succeed simply because it is safer to
follow the crowd from a career
perspective. He stated that following
the herd never results in a quantum
leap forward. This means exploiting

strong and novel science with rigorous
scientific discipline to bring true
improvements in the treatment of
disease.
Balancing Idealism and Realities of
Business for a Higher Purpose
The biotech and biopharma space is
constantly in a state of flux, evolving
faster than a speeding bullet. Keeping
up with the latest technologies and
science can be a daunting task, but it’s
not the only challenge. The varied
needs of clients also pose a problem, as
the requirements of the job are ever-
changing, and the expectations are
constantly rising. This has forced him
to stay on his toes, always looking for
the next big opportunity and continu-
ally re-inventing his career. He says,
“It’s a thrilling but challenging ride,
but ultimately, it’s a journey I wouldn’t
trade for anything else.”
Juggling the complex needs of biotech
and biopharma clients while staying
true to his idealism has been a constant
challenge for Dr. Mark Levitt. Working
in a rapidly evolving field and striving
to find a balance between the financial
bottom line and serving as a force for
good has been no small feat. But as he
has come to a realization, the drive to
cure those diseases with the direst
consequences can also be a source of
financial reward for investors and
companies. Throughout years of
pushing himself out of his comfort
zone and re-inventing his career, he has
remained determined to stay focused
on helping others—no matter the cost.
He says, “For me, the trick is never to
lose sight that helping others is the
primary driver—not the money.” In
recent years, we have seen in oncology
that those new therapies that offer the
most benefit to patients are the ones
that become mega-blockbusters,
substantiating the philosophy that
helping others by developing better
treatments is, in the end, a win-win for
all of the stakeholders.
Revolutionizing Oncology Care
For the last decade, Dr. Mark Levitt
has been a driving force in the
pharmaceutical industry, launching
groundbreaking research projects and
developing new treatments. Now, he’s
looking ahead, establishing a fund to
support early-stage oncology projects
that may be high-risk but could lead to
disruptive technology. His clients
range from the United States to Israel,
Australia, and beyond. He’s on an
ambitious mission to change the field
of oncology. With these cutting-edge
investments, he hopes to bring the
therapies of the future to those in need
while also propelling further progress
in the fight against cancer.
Middle East's 10 Successful Magne c Leaders Revamping The Healthcare Vol II

Subscription
CIO
THE
CI
Global
Subscrip on
Create
Excellence
Choose
Subscribe to
THECIOWORLD
Get THECIOWORLD Magazine in Print, &
Digital on www.thecioworld.com
CIO

We take
immense pride
in our
commitment
to ensure that our
customers, and in
particular our
patients, are at
the core of
our operations.
Mr. Ryan Fernandes
Head of Marketing - GCC
Aster DM Healthcare
www.thecioworld.com August, 2023
16

Fernandes
Driving Marketing Excellence and Revitalizing Brands for
Sustainable Growth!
he healthcare industry is a complex and ever-
Tevolving field that plays a crucial role in our
society. With advancements in technology, changes
in regulations, and shifting demographics, it is a sector that
requires constant attention and adaptation.
Ryan Fernandes, with his extensive experience and
achievements, stands out in this industry. Having worked in
the Middle East, Africa, the UK, and India for over 20
years, Fernandes has become a highly skilled professional
in eCommerce and Marketing, leaving a lasting impact on
the industry.
As a renowned marketing and digital strategy expert,
Fernandes has a proven track record of fostering
intercultural teamwork and fostering growth for Fortune
500 firms across a range of industries. His knowledge
covers multiple industries, including FMCG, consumer
technology, healthcare, and retail. This allows him to
successfully negotiate challenging environments and
produce outstanding outcomes.
In addition to brand building and transformation, customer
loyalty and CRM, customer analytics, innovation and
product development, digital transformation, and digital and
performance marketing are some of the areas in which
Fernandes excels. Every aspect of the subject is covered by
his all-encompassing approach to marketing, resulting in
complete strategies that promote long-term growth and
achieve market dominance.
With a deep understanding of both business and consumer
dynamics, Fernandes excels in communication,
collaboration, team management, and stakeholder
engagement at all levels of an organization. His strategic
vision and ability to build strong cross-functional teams
have propelled him to the position of Head of Marketing,
Branding, and Communications in the GCC for Aster
Hospitals, Clinics, Retail, and Digital Health.
He oversees a group of over 50 employees to 45 at Aster
DM Healthcare who are in charge of implementing
effective marketing strategies across various industries,
boosting brand recognition, and driving revenue growth.
Join us as we delve into his remarkable journey!
Please brief us about yourself and your background
before you entered the Healthcare Sector.
I am a seasoned Marketing and Digital Strategy
professional, bringing more than two decades of success in
spearheading growth for Fortune 500 companies across
diverse sectors, including Healthcare, Retail, Consumer
Technology, and FMCG. My proficiencies encompass an
array of areas, including brand building and transformation,
customer relationship management, customer analytics,
product development, digital transformation, and growth
leadership. Over the years, I’ve honed my communication,
collaboration, and team management skills, allowing me to
successfully engage with stakeholders at all levels of an
organization.
Before my current role as the Head of Marketing for the
GCC at Aster DM Healthcare Group, I held a series of high-
profile positions across leading organizations. Notable
amongst these was my tenure as VP – Marketing &
eCommerce at Pantaloons (Aditya Birla Fashion Retail
Ltd), where I led Brand Strategy, Campaigns, Digital,
Social & Influencer Marketing, CRM & Loyalty program,
Consumer Analytics & Research, and PR, while also having
P&L accountability for Pantaloons D2C eCommerce
business.
Before Pantaloons, I served at HMDGlobal (Nokia Phones)
as the Global eCommerce & GTM Lead, overseeing the
Global eCommerce strategy & business. My responsibilities
Pioneering Growth and
Brand Transforma on in Healthcare
17

extended to defining and building the organizational structure,
budget, business processes, and platform architecture. I also
played a crucial role in executing the eCommerce platforms
across countries and leading the Go-To-Market Program for
Nokia mass-market smartphones globally.
Earlier in my career, I held strategic roles at Microsoft and
Nokia in the areas of Marketing Planning, Operations, and
Analytics. In these roles, I was instrumental in maintaining
regional profitability above target levels and launching high-end
smartphones successfully.
My early professional journey also includes tenures at GSK
Consumer Healthcare India Ltd and Nestle India Ltd, where I
contributed to the relaunch of key brands, achieving market
leadership in specific categories and initiating profitable
strategies.
I hold an MBA from the Indian Institute of Management
(IIM), Calcutta. Additionally, I have furthered my
knowledge and skills through certification programs
such as ‘Online Business Strategy and Financial
Acumen’ by Microsoft-INSEAD and ‘Management &
Leadership’ by the Nokia-Wharton Voyager Program.
Overall, my journey before venturing into the healthcare
sector has been marked by continual learning, impactful
leadership, and a steadfast commitment to driving
growth through innovative marketing strategies. I am
excited to leverage these experiences as I continue to
contribute to the healthcare industry.
Please brief our audience about your company, its
USPs, and how it is currently positioned as a
prominent name in this industry.
Aster DM Healthcare is a large multinational healthcare
services company with hospitals, clinics, and pharmacies
in India, the United Arab Emirates, Qatar, Kuwait,
Bahrain, Saudi Arabia, and Oman. It was founded in
1987 by Dr. Azad Moopen and is headquartered in
Dubai, UAE.
Aster DM Healthcare has a network of over 885
healthcare facilities, including 32 hospitals, 127 clinics,
521 pharmacies, and 205 labs & PECs. The company
provides a wide range of healthcare services, including
inpatient, outpatient, diagnostic, and preventive care.
Aster DM Healthcare is committed to providing high-
quality, affordable healthcare to its patients. The
company has been recognized for its quality standards
by several organizations, including the Joint Commission
International (JCI), the National Accreditation Board for
Hospitals & Healthcare Providers (NABH), and the
Healthcare Information and Management Systems
Society (HIMSS). In 2022, Aster DM Healthcare was
named one of the top 100 companies in India by Fortune
India.
The company was also ranked as the 4th best hospital
chain in India by the National Patient Satisfaction
Survey. Linkedin ranks Aster amongst the top 5
preferred employers in UAE.
Aster DM Healthcare is a leading provider of healthcare
services in India and the Middle East. The company is
committed to providing high-quality, affordable
healthcare to its patients and is constantly striving to
improve its standards.
18

What motivated you to pursue a career in the healthcare
industry?
Following two decades of occupying strategic leadership
roles in Marketing, Go-to-Market strategies, and Digital
Transformation within consumer-centric industries such as
Fast Moving Consumer Goods (FMCG), Telecommunications,
and Retail Fashion, I found myself embarking on an
unpredictable journey, profoundly impacted by the Covid-
19 pandemic. The global health crisis illuminated the need
for a paradigm shift in how we perceive health and
wellness, underscoring their importance and shaping them
as top priorities for every individual.
While scrutinizing the healthcare sector, I observed that its
modus operandi has traditionally been clinically driven - its
primary objective being to restore health to ailing patients
rather than espousing a holistic approach to health and
wellness. Moreover, in the spectrum of digital transformation,
the healthcare industry has been lagging in comparison to
its consumer-facing counterparts. A comparative lack of
emphasis on digital progression, paired with a lower
investment quotient for enhancing digital consumer
experiences, was quite evident.
Perceiving these elements, I identified a significant
opportunity for growth and change. I recognized that the
industry was at a critical juncture where it was ready to
transition from a predominantly clinical focus to a more
holistic wellness model, necessitating the application of
modern marketing strategies and digital transformation
methodologies. Therein, I found my inspiration to venture
into the healthcare sector. The prospect of leveraging my
expansive experience to drive this pivotal transformation in
an industry so crucial to the well-being of mankind is a
challenge that I am both excited about and prepared to
undertake.
Currently,As the Head of Marketing, Brand & Communication
in the GCC, I lead a 45-member team at Aster Hospitals,
Clinics, Retail & Digital Health for the Marketing programs
and demand growth across the Business Units.
How have you rekindled focus around patient care in
your organization?
With the expansion of an organization, it is not uncommon
to observe a growing emphasis on procedural efficiency and
operational standardization, which may inadvertently cause
a decline in patient-centered care. However, at Aster, we
take immense pride in our commitment to ensure that our
customers, and in particular our patients, are at the core of
our operations.
We have undertaken a series of strategic initiatives to
rekindle and augment the focus on patient care. One of
these involved empowering our Customer Care and Service
Excellence personnel with the authority and encouragement
to go beyond the routine procedures to delight our customers.
This was achieved through comprehensive internal
capability-building exercises. These exercises led to the
institution of internal reward and recognition programs
designed to cultivate and motivate the staff to consistently
prioritize patient care, thereby ensuring an organizational
culture that puts patients first.
Simultaneously, we embarked on an extensive brand-
building campaign under the powerful and resonating
slogan, “Care is just an Aster Away.” This campaign was
aimed at reassuring our patients of our unwavering commitment
to their care while also showcasing our expansive healthcare
network across the UAE. Our campaign activations spanned
various media platforms such as Out-of-Home advertising
(OOH), transportation, print, digital, Below-the-Line (BTL)
advertising, and various events.
A hallmark of this campaign was leveraging the occasion of
Aster’s 35th Anniversary to project our message of care
onto the façade of the iconic Burj Khalifa, the world’s
tallest building. This event not only significantly enhanced
our brand visibility and saliency but also instilled a strong
sense of pride within our organization, renewing our
collective commitment to living up to this promise of
ensuring that “Care is just an Aster Away.”
In essence, by creating an organizational culture that values
patient care above all and projecting this commitment
through our strategic brand-building campaign, we have
reinvigorated our focus on patient care within the Aster
organization.
19

he healthcare industry has been
Twitnessing a remarkable transformation
in recent years, driven by cutting-edge
innovations and breakthrough technologies.
These advancements are revolutionizing the
way healthcare is delivered, improving patient
outcomes, and enhancing the efficiency of
medical practices. From AI-driven diagnostics
to personalized medicine, the healthcare
landscape is undergoing a paradigm shift that
holds promise for a healthier and more
sustainable future.
The Rise of Artificial Intelligence in
Diagnostics
Artificial Intelligence (AI) has emerged as a
game-changer in healthcare diagnostics. AI
algorithms, fueled by extensive data sets and
machine learning, are enabling faster and more
accurate diagnosis of diseases. For instance, AI-
powered image analysis is enhancing the
accuracy of medical imaging interpretations.
Cutting-Edge
Innova ons and
Breakthroughsin
Healthcare
INDUSTRY
20

21

Radiologists and pathologists are now aided by algorithms
that can detect subtle anomalies that might be missed by
human eyes alone. This not only expedites the diagnostic
process but also reduces the chances of misdiagnosis.
Personalized Medicine and Genomics
The field of genomics has paved the way for personalized
medicine, tailoring treatment plans to an individual's
genetic makeup. The ability to sequence an individual's
genome has led to more precise diagnosis, treatment, and
prevention strategies. With genomic insights, doctors can
predict a patient's susceptibility to certain diseases, identify
the most effective medications, and develop targeted
therapies. This approach not only improves patient
outcomes but also minimizes adverse drug reactions,
ultimately leading to a more efficient healthcare system.
Telemedicine and Remote Patient Monitoring
Telemedicine has transcended geographical barriers,
enabling patients to access medical expertise regardless of
their location. The COVID-19 pandemic further accelerated
the adoption of telemedicine, allowing patients to consult
healthcare professionals virtually. Beyond consultations,
remote patient monitoring devices are now capable of
continuously tracking vital signs and health metrics. This
real-time data empowers physicians to intervene proactively
and make informed decisions, reducing hospital
readmissions and improving chronic disease management.
Robotics and Minimally Invasive Surgery
Robotic technology has revolutionized surgical procedures,
making them less invasive and more precise. Robotic-
assisted surgeries offer surgeons enhanced visualization,
greater dexterity, and the ability to perform complex
procedures through smaller incisions. This translates to
reduced pain, shorter hospital stays, and quicker recovery
times for patients. As robotic systems continue to evolve,
the boundaries of what is possible in the operating room are
expanding, paving the way for even more intricate and
delicate procedures.
Blockchain for Data Security and Interoperability
Blockchain technology is addressing two critical challenges
in healthcare: data security and interoperability.
Blockchain's decentralized and tamper-resistant nature
ensures the privacy and integrity of patient data,
safeguarding it from breaches. Moreover, it enables secure
sharing of medical records across different healthcare
providers. This interoperability enhances the continuum of
care by giving healthcare professionals access to
comprehensive patient histories, resulting in better-
informed decisions and coordinated treatments.
3D Printing in Medical Applications
The applications of 3D printing in healthcare are as diverse
as they are revolutionary. Customized implants, prosthetics,
and anatomical models can now be fabricated with
remarkable precision using 3D printing technology.
Surgeons can use these models to plan complex surgeries
and practice intricate procedures before entering the
operating room. In addition, 3D-printed organs and tissues
are being explored as a solution to the organ transplant
shortage, potentially revolutionizing the field of
regenerative medicine.
22

Nanomedicine and Targeted Drug Delivery
Nanotechnology is unlocking new possibilities in drug
delivery and treatment strategies. Nanoparticles can be
engineered to carry medications directly to specific cells or
tissues, minimizing side effects and maximizing therapeutic
impact. This targeted drug delivery approach improves drug
efficacy while reducing the dosage required. Nanomedicine
is particularly promising in cancer treatment, where it
allows for the precision delivery of chemotherapy agents to
cancer cells, sparing healthy tissues and mitigating adverse
effects.
Virtual Reality and Pain Management
Virtual Reality (VR) is making strides in managing pain
and anxiety during medical procedures. By immersing
patients in calming and engaging virtual environments, VR
distracts from the discomfort and stress associated with
medical interventions. It has proven effective in reducing
pain perception during wound dressing changes, dental
procedures, and even labor. Additionally, VR is being used
for physical therapy and rehabilitation exercises, enhancing
patient engagement and adherence to treatment plans.
Bioinformatics and Drug Discovery
The complex process of drug discovery and development is
being streamlined by bioinformatics, the marriage of
biology and data science. Advanced computational models
analyze vast datasets to predict how potential drug
compounds will interact with biological systems. This
accelerates the identification of promising drug candidates
and expedites the research timeline. By combining
molecular biology with data-driven insights, bioinformatics
is catalyzing the discovery of novel treatments for various
diseases.
The Future of Healthcare: Challenges and
Opportunities
While these cutting-edge innovations hold immense
potential, they also bring forth challenges that need to be
addressed. Ensuring data privacy and security in an
interconnected healthcare ecosystem is paramount.
Regulatory frameworks must adapt to the rapidly evolving
landscape, maintaining a balance between innovation and
patient safety. Furthermore, equitable access to these
advancements remains a concern, as not all communities
may benefit equally from these breakthroughs.
To Conclude,
The healthcare industry is undergoing a profound
transformation fueled by cutting-edge innovations. From
AI-driven diagnostics to personalized medicine, these
breakthroughs are redefining patient care, treatment
strategies, and the overall healthcare experience. As
technology continues to evolve, collaboration among
healthcare professionals, researchers, and technology
experts will be key to realizing the full potential of these
innovations. By overcoming challenges and embracing
opportunities, the healthcare industry is poised to
revolutionize healthcare delivery and improve the well-
being of individuals worldwide.
23
-Prh D. Bombarde

The world faces numerous challenges, including
biodiversity loss, deforestation, waste disposal, air
pollution, water insecurity, toxic loads, plastic
pollution, global warming, and climate change. These
issues contribute to increasing inequities and social
stressors, leading to a perilous future for civilization. The
United Nations General Assembly approved 17 goals in
2015 to address global concerns, such as poverty,
inequality, energy, peace, and climate change. The 17
Sustainable Development Goals (SDGs) are interrelated
and achieving one will result in achieving the others.
Nanotechnology, an interdisciplinary field involving
researchers from various fields, has the potential to
transform industries and open new avenues for innovation
and discovery, thereby contributing to the achievement of
the 17 SDGs.
Nanotechnology has the potential to revolutionize our lives,
including health, environment, and infrastructure. By
collaborating with experienced teams and leveraging
nanotechnology, we can work towards achieving these
goals and promoting a more sustainable future for all.
Nanotechnology can enhance drug delivery, diagnostics,
medical imaging, medical devices, and tissue engineering.
Nanorobots can be used for targeted medicine administration
or minimally invasive surgery, while nanoparticles can
encourage cell growth and regeneration in injured tissues.
Nanotechnology-based filters can eliminate water
pollutants, while nano-porous membranes filter out salt and
other pollutants. Nano-sensors can monitor water quality in
real-time.
Additionally, Nanotechnology can enhance infrastructure,
advance renewable energy sources, and improve
manufacturing techniques. It can also increase efficiency
and reduce waste, leading to more environmentally friendly
and economically viable production techniques.
Nanotechnology-based water treatment technologies can
reduce waste and increase water treatment plants' efficiency.
Nanotechnology can also help cities and communities to be
more sustainable by improving insulation, water treatment,
air pollution reduction, and real-time infrastructure
monitoring. It can also improve urban transportation
networks by creating self-healing building materials,
improving insulation, coatings, and energy production.
Nanotechnology-based materials can also be used for
responsible consumption and production, making
manufacturing processes more energy efficient and reducing
waste.
Nanotechnology can also help to conserve ocean, sea, and
marine resources sustainably by cleaning water bodies of
pollutants and detecting water pollution levels.
Nanostructured materials like graphene-based sorbents or
carbon nanotubes can effectively absorb oil from water
surfaces, whereas graphene oxide membranes or carbon
nanotubes can filter out salt ions for drinking and irrigation
purposes. Nanoparticles can also enhance drug delivery
systems for marine organisms, protecting coral reefs and
promoting coral growth.
Nanotechnology-based materials can also be used to
remediate contaminated soils, improve soil quality, and
monitor environmental factors in real-time. These
technologies can also be used to develop new conservation
technologies that protect endangered species and boost
biodiversity.
24

25

Furthermore, nanotechnology has the ability to enhance
infrastructure, promote sustainable consumption and
production, reduce poverty, promote zero hunger, and
assure inclusive and equitable quality education.
Nanotechnology has the potential to contribute to various
goals, including enhancing learning, promoting gender
equality, promoting economic growth, reducing
inequalities, and promoting peace, justice, and strong
institutions. It can be used in various sectors, such as
healthcare, agriculture, and education, to provide targeted
drug delivery systems, early detection methods, and
personalized treatments. Nanomedicine can revolutionize
healthcare by providing targeted drug delivery systems,
early detection methods, and personalized treatments,
addressing challenges related to menstrual health and
hygiene.
In agriculture, nanotechnology can improve crop yields,
soil fertility, and pest control methods, empowering women
farmers and increasing their productivity and income. In the
energy sector, nanotechnology-based solutions like solar
cells, energy storage devices, and efficient lighting systems
can provide sustainable energy alternatives, reducing the
time spent on energy-related chores.
Nanotechnology can drive economic growth and create new
job opportunities in various sectors, such as research and
development, manufacturing, energy, healthcare, and
agriculture. The development of nanotechnology-based
products requires significant research and development,
creating jobs in the manufacturing sector. Additionally,
nanotechnology-based medical devices and therapies can
improve healthcare outcomes and create jobs in the
healthcare industry.
Reducing inequalities is another goal for sustainable
development, as it aims to ensure equal access to resources,
opportunities, and basic services. Nanotechnology-based
medical devices and diagnostic tools can help bridge the
gap in healthcare access, providing affordable and portable
solutions. Nanomaterials can be employed to develop
efficient water purification systems, self-cleaning surfaces,
and antimicrobial coatings for sanitation facilities,
improving hygiene standards.
In education, nanotechnology-based educational tools and
materials can provide engaging and accessible learning
experiences for all students. Low-cost educational devices
and platforms can enable remote learning opportunities for
underserved populations. In energy, nanotechnology-based
solutions can promote access to clean and affordable energy
sources, empowering communities to generate their own
clean energy and reducing energy poverty.
Thus, nanotechnology has the potential to help achieve
these goals, promoting peace, justice, and strong institutions
for sustainable development. Nanotechnology has the
potential to significantly advance the United Nations' 17
Sustainable Development Goals by contributing to forensic
science, promoting peace, and enhancing security measures.
Forensic investigations play a crucial role in ensuring
justice and maintaining law and order. Nanosensors and
nanoparticles can enhance forensic analysis, while
nanomaterials can enhance security systems and data
security. Nanotechnology can also address environmental
challenges by providing sustainable alternatives, such as
water purification and wastewater treatment. Nanotechnology-
enabled sensors can monitor air quality, soil health, and
water pollution, enabling early detection and prevention of
environmental hazards.
Furthermore, nanotechnology can support access to justice
by improving legal processes and enhancing forensic
capabilities. Nanoscale materials can be used for evidence
preservation, analysis of complex legal documents, and the
development of secure and tamper-proof identification
systems. Partnerships between academia, industry, and
government agencies can drive economic growth and job
creation. Nanotechnology can also promote global
partnerships for sustainable manufacturing practices,
reducing carbon footprints and minimizing environmental
impact.
In conclusion, nanotechnology has the potential to
significantly advance the United Nations' 17 Sustainable
Development Goals by contributing to the development of
cost-effective, accessible, and environmentally products and
materials. However, it is crucial to consider potential
negative effects on the environment and health. Responsible
development and regulation are essential to ensure the
secure and long-term application of nanotechnology in
achieving these goals.
26

Unleashing
the
POWER of
TECHNOLOGY
28

he healthcare industry stands on the cusp of a
Ttransformative era driven by the relentless
advancement of technology. From precision
medicine to telehealth, these innovations are reshaping the
landscape of healthcare, promising better patient outcomes,
enhanced efficiency, and improved accessibility. As we peer
into the future, it's clear that technology will play an
increasingly pivotal role in revolutionizing healthcare as we
know it.
Precision Medicine: Personalizing Healthcare
One of the most promising advancements in healthcare is
precision medicine, an approach that tailors medical
decisions and treatments to the individual characteristics of
each patient. This entails analyzing an individual's genetic
makeup, lifestyle, and environmental factors to design
personalized treatment plans. With the advent of genomics
and advanced data analytics, doctors can predict disease
susceptibility, select the most effective therapies, and even
anticipate adverse reactions to medications. Precision
medicine not only increases treatment efficacy but also
reduces the risk of side effects, making healthcare truly
patient-centered.
Telehealth and Remote Monitoring: Breaking
Geographical Barriers
Telehealth has rapidly gained traction, especially in recent
times, with the COVID-19 pandemic accelerating its
adoption. This technology-driven approach enables patients
to consult medical professionals remotely, breaking down
geographical barriers and enhancing access to healthcare
services. Telehealth encompasses virtual consultations,
remote monitoring of vital signs, and even digital
prescriptions. Patients in rural or underserved areas can
now receive expert medical advice without the need to
travel long distances, while healthcare providers can extend
their reach beyond their physical locations.
IoT and Wearables: Tracking Health in Real Time
The Internet of Things (IoT) has introduced a new
dimension to healthcare by enabling the development of
wearable devices that continuously monitor various health
metrics. From smartwatches that track heart rate and sleep
patterns to glucose monitors for diabetes management,
these wearables provide real-time data to users and
healthcare providers. This real-time data empowers
individuals to proactively manage their health and doctors
to make more informed decisions. Wearables not only
The Future of Healthcare
29

facilitate early detection of health issues but also promote
preventive measures, reducing the burden on healthcare
systems.
Artificial Intelligence and Machine Learning:
Enhancing Diagnostics
Artificial Intelligence (AI) and Machine Learning (ML)
algorithms are revolutionizing the diagnostic process in
healthcare. These technologies can analyze vast amounts of
data, ranging from medical images to patient records, to
identify patterns and anomalies that might be imperceptible
to human eyes. AI-powered diagnostic tools are becoming
increasingly accurate in detecting diseases such as cancer,
enabling earlier intervention and improved treatment
outcomes. Moreover, these technologies continuously learn
and adapt, refining their diagnostic capabilities over time.
Robotics in Surgery: Precision and Innovation
Robot-assisted surgery is reshaping the field of surgical
procedures. With robotics, surgeons can perform intricate
and complex procedures with enhanced precision and
dexterity. Robotic surgical systems offer magnified 3D
visualization and fine motor control, reducing the
invasiveness of procedures and shortening recovery times.
While the surgeon remains in control, the robot's precise
movements minimize the risk of human error. As
technology advances, the potential for remote robotic
surgeries and collaboration among surgeons across the
globe holds immense promise.
Blockchain: Secure and Interoperable Data Sharing
In a data-driven healthcare landscape, maintaining the
security and integrity of patient information is paramount.
Blockchain technology offers a solution by providing a
secure and tamper-proof way to store and share sensitive
medical data. Patients have greater control over their
health records, and healthcare providers can access a
comprehensive medical history across different institutions.
This not only streamlines care coordination but also
enhances patient privacy and data security, addressing
concerns about data breaches and unauthorized access.
Virtual Reality and Mental Health: Immersive Healing
Beyond physical health, technology is also making strides
in mental healthcare. Virtual Reality (VR) is being
employed to treat conditions like anxiety, PTSD, and
phobias by creating controlled, immersive environments for
therapy. Patients can confront their fears in a controlled
setting, reducing anxiety and facilitating healing.
Additionally, VR offers relaxation and mindfulness
experiences, promoting mental well-being. As mental health
gains prominence, the integration of technology in
therapeutic interventions marks a significant step toward
holistic healthcare.
Predictive Analytics: Anticipating Outcomes
Predictive analytics leverages historical data and statistical
algorithms to forecast potential outcomes. In healthcare,
this technology is used to predict disease outbreaks, patient
readmissions, and even individual patient risks. By
identifying high-risk patients, healthcare providers can
intervene proactively to prevent complications and
hospitalizations. Predictive analytics also aids in resource
allocation, enabling hospitals to manage patient influxes
efficiently.
Challenges and Considerations
As we embrace the future of healthcare technology, it's
crucial to address the challenges that arise. Privacy
concerns, ethical implications of AI, and the digital divide
must be carefully navigated. Ensuring data security and
patient consent is paramount to maintaining trust.
Furthermore, integrating new technologies into existing
healthcare systems requires seamless interoperability and
training for healthcare professionals.
The Promising Horizon
The future of healthcare is undeniably exciting as
technology continues to unlock possibilities that seemed
inconceivable just a few years ago. Patient-centered care,
driven by precision medicine, will become the norm, while
telehealth and wearables will bridge gaps in accessibility.
The synergy of AI, IoT, and blockchain will usher in an era
of data-driven decision-making and secure information
exchange.
As we move forward, collaboration between healthcare
professionals, technologists, policymakers, and patients will
be essential. It is through this collaboration that we can
ensure that the power of technology is harnessed for the
betterment of healthcare worldwide. By leveraging these
innovations, we have the potential to create a healthcare
ecosystem that is more efficient, personalized, and
ultimately focused on improving the health and well-being
of individuals across the globe.
30
-AdibaTarade

Yuval Harpaz
IT Director
KAMADA
32

HARPAZ
Sharing Innova ve Exper se
for Two Decades
Yuval
echnology is the application of knowledge to
Tachieve practical goals consistently and predict-
ably. The advances in technology have geared up
everyone’s future. But to use technology appropriately,
one needs the right amount of knowledge to apply it in
the right way.
The pharmaceutical industry has seen a shift from its
traditional methods to technological advances. With the
growth in technology, different approaches and strategies
were involved in delivering a better future for the
industry.
Adapting to the changes and building up a better version
of advancement, Yuval Harpaz has brought in new
advancements with his 20 years of experience. Explain-
ing his journey from the start till date, he has given a
clear picture of how technology emerged he was able to
manage it.
Being an effective leader, Yuval Harpaz, the IT
Director at KAMADA, has supported the global
expansion of the company. Business continuity is his
main vision. With all the difficulties arising, he always
made the process of continuation easy for him and his
team. Facing all the challenges and moving ahead made
him a true business leader.
WHEN I JOINED KAMADA,
I HAD THE OPPORTUNITY TO
EXECUTE PROJECTS AND
ACTIVITIES USING MY DEEP
KNOWLEDGE AND
EXPERIENCE IN THESE AREAS.
Let’s get into detail with the story of Yuval Harpaz to
understand how his expertise made him an effective
business leader:
Stepping Stones to Success
Yuval Harpaz is a BA in Economics and Logistics from
Bar Ilan University and an MA in Business Administra-
tion with a specialization in Information Technology and
Marketing from Hebrew University.
For the past four years, he has worked as an IT Director
for KAMADA, a commercial-stage global
biopharmaceutical company with a portfolio of marketed
products indicated for rare and serious conditions. Began
his career in 2002 as an ERP consultant at Oracle
Software as a team leader and project manager for global
ERP and CRM projects. He has over 20 years of
experience with Information Technology Systems and
cyber security.
In 2008, he joined Check Point Security and was in
charge of a global CRM (Salesforce) rollout spanning 20
countries, 600 salespeople and managers, and 3,500
partners. He also conducted a development project of a
unique mechanism for sales opportunities and a non-
standard pricing model. Implementing a highly compli-
cated algorithm for discounts and approval workflow
across the global sales organization. The solution is
working today.
In 2012, he joined Retalix Software as a global applica-
tions director, managing all business applications (ERP,
CRM, BI, R&D, and Quality). When Retalix was
acquired by NCR Systems in 2014, Yuval oversaw the
entire applications integration project for two years until
a full global implementation. In 2017, he was hired as
the CIO of Danel LTD.
,
,
,,
33

Danel is a large Israeli firm that specializes in nursing,
human resources, and special needs populations. Danel
has approximately 20,000 employees and 200 locations
throughout Israel. Throughout his role, he upgraded the
network and cyber security capabilities and implemented
new ERP and CRM applications. Yuval joined Kamada
in 2019 as an IT Director, establishing a new department
to address pharmaceutical IT challenges in the areas of
quality, cyber security, network infrastructure, support,
and business applications.
KAMADA’s Mission & Vision
A leader in the specialty plasma-derived field focused on
diseases of limited treatment alternatives, Kamada is
engaged in the commercialization, manufacturing, and
development of biopharmaceutical products, including
six FDA-approved products. Kamada is a small to mid-
size pharma company, but its IT challenges are compara-
ble to those of the largest pharma companies. Yuval
explained his role as an IT Director in Kamada, stating,
“I must provide the growth infrastructure, support the
Company’s global expansion, supply up-to-date
applications to run the business processes, all under a
very tight regulation and quality controls as well as
ensure data integrity and Security.”
Approaches and Strategies
KAMADA’s IT department is part of the Company’s
corporate headquarters; as IT Director, there’s
a bigger picture of short and long-term needs that
necessitates a dedicated IT strategy.
Yuval installs a “Keep Business Running” mentality in
his team. As a team, they must ensure business continu-
ity, allow continued plant manufacturing, quality, and lab
functionality, as well as develop and implement new
applications and capabilities. All the activities must
adhere to higher mandated standards and address quality
regulations while staying within approved budgets.
Senior Management’s understanding of the IT impor-
tance is crucial to allow for sustained growth and
achieving corporate goals; it is crucial that the IT short
and long terms strategy be aligned with and support the
corporate strategy.
Future needs, planned expansion, marketing activities, as
well as new regulations and procedures, must all be
considered in the IT strategic plan. KAMADA’s global
expansion necessitates adaptation of based cloud
applications as well as other new tools and procedures,
which will allow the IT team to better support the
company employees wherever they are.
Kamada’s Prominent Features
Kamada is a leader in the specialty plasma-derived field,
with products indicated for rare and serious conditions in
areas of limited treatment alternatives. Kamada’s
products are distributed in more than 30 markets
worldwide. Kamada has long-standing commercial
relationships with several of the largest plasma compa-
nies and leverages more than 30 years of experience to
support its growth and expansion strategy.
Two Decades of Experience
Talking about this industry, Yuval claims that the
pharmaceutical industry characteristics are materially
different from all other industries he used to work for.
The manufacturing plant’s IT support is available 24
hours a day, there is a procedure for each process, the
documentation is highly focused, and finding solutions
is in a very creative way to keep the business running
while also promoting new cloud-based technologies.
In his previous roles, he built the landscape in three
major IT areas: system and infrastructure, business
applications, and cyber security. But things were
different in Kamada. When he joined Kamada, he used to
execute projects and activities based on his extensive
knowledge and experience in these areas. Every com-
pany he worked for him. He has gained a lot of expertise
in market operations, the company DNA, the firm’s
unique characteristics, and the areas IT should focus on
to keep the business running and implement new
technologies.
Market Support and Leveraging for Plasma-Driven
Protein Therapeutics
With business-focused applications, high-availability
networks, and cyber security technologies, IT at Kamada
enables sales, marketing, quality control, regular affairs,
manufacturing, and R&D, as well as all corporate
functions. The support Processes, team, and monitoring
systems are all tailored to the needs of the business.
One example is pharmaceutical product serialization
requirements - each manufactured product requires to
34

have a unique serial number, identification barcode, as
well as additional data to enable global Traceability. Due
to systems complexity and different serialization
requirements for each territory, IT solutions and support
are required to be agile and adaptive. The team maintains
state-of-the-art machines, supported network connec-
tions, as well as dedicated personnel and procedures to
enable products to be distributed globally while meeting
all serialization requirements.
Challenges Encountered
During the past year, Yuval had to reposition the IT
department as a global support that supports the com-
pany’s expansion into new business initiatives and
territories. Earlier, the COVID-19 pandemic posed other
challenges, such as the need to transition from office-
based operations to a hybrid one, requiring a company-
wide ‘go-mobile” project and adapting security systems
and protocols to allow for continued safe operation in the
new remote settings, and all through successfully
managing mandatory constraints on employees (includ-
ing IT’s) ability to work from the office. Eventually, it
became second nature to the IT team.
Global Outreach In Future
KAMADA continues its expansion and increasing its
market presence in many other regions, and its IT
department, led by Yuval, will continue to enable such
growth and lead the company’s technological
advancements.
Advancements as an IT Director
Many new technologies, cloud-based applications,
enhanced cyber security threats, and business-changing
needs are pushing the modern CIO to be the trusted
technological advisor and one of the main business
enablers. To fulfill such a role, a CIO should spend the
first years of his or her career learning the three main
building blocks (Infrastructure and Support, Business
Applications, and Cyber Security) and gaining
experience in IT roles from the bottom up until the CIO
role.
35

“Time and health are
two precious assets that
we don’t recognize and
appreciate until they
have been depleted.”
– Denis Waitley

www.thecioworld.com
THE
CI

V1 Middle East's 10 Successful Magnetic Leaders Revamping The Healthcare.pdf

Recommended

Recommended

More Related Content

Similar to V1 Middle East's 10 Successful Magnetic Leaders Revamping The Healthcare.pdf

Similar to V1 Middle East's 10 Successful Magnetic Leaders Revamping The Healthcare.pdf (20)

More from THECIOWORLD

More from THECIOWORLD (20)

Recently uploaded

Recently uploaded (20)

V1 Middle East's 10 Successful Magnetic Leaders Revamping The Healthcare.pdf